Medical News

[Medical News][bleft]

Pharmacy Research

[Pharmacy Research][bleft]

Lifestyle

[Lifestyle][bsummary]

Pantoprazole: Dosage, Side Effects, Brands & Clinical Use | MedexInfo

Pantoprazole: Uses, Dosage, Side Effects & Brands | MedexInfo

Pantoprazole

OTC / Rx
Generic NamePantoprazole
Therapeutic ClassProton Pump Inhibitor (PPI)
Common Dose40 mg daily
Max / 24h80 mg
PregnancyCategory B
Indications ▼
Gastroesophageal reflux disease (GERD)
Peptic ulcer disease (gastric & duodenal)
Helicobacter pylori eradication (combination therapy)
Zollinger-Ellison syndrome
Prevention of NSAID-induced ulcers
Mechanism & Pharmacokinetics ▼
Mechanism: Irreversibly inhibits H+/K+ ATPase in gastric parietal cells, reducing gastric acid secretion.
Pharmacokinetics: Oral bioavailability ~77%. Tmax ~2.5 hours. Metabolized in liver (CYP2C19 & CYP3A4). Half-life ~1 hr. Excreted in urine & feces.
Dosage & Administration ▼
Patient CategoryRecommended DoseMax / 24 Hours
Adults (GERD)40 mg once daily before meal80 mg
Peptic Ulcer / H. pylori40 mg daily in combination therapy80 mg
Pediatric (≥6 yr)20–40 mg daily40 mg
Side Effects ▼
Common: Headache, nausea, diarrhea, abdominal pain
Less Common: Dizziness, flatulence, constipation
Serious: Hypomagnesemia, Clostridium difficile infection, osteoporosis-related fractures (long-term use)
Contraindications ▼
Hypersensitivity to Pantoprazole or any PPI
Severe hepatic impairment (use with caution)
Drug Interaction ▼
Clopidogrel: May reduce antiplatelet effect
Warfarin: May increase INR
Ketoconazole / Itraconazole: Reduced absorption due to decreased gastric acidity
Pregnancy & Lactation ▼
Generally considered safe (Category B)
Use caution during breastfeeding
Clinical / Research Summary ▼
Proton Pump Inhibition: Pantoprazole is a selective proton pump inhibitor that provides effective and sustained suppression of gastric acid secretion by irreversible inhibition of the H⁺/K⁺-ATPase enzyme in gastric parietal cells.
GERD and Esophagitis: Clinical trials confirm high healing rates of erosive esophagitis and significant symptom improvement in patients with gastroesophageal reflux disease, including moderate to severe cases.
Stress Ulcer Prevention: Widely used in hospitalized and critically ill patients for prevention of stress-related mucosal damage and upper gastrointestinal bleeding.
H. pylori Therapy: Pantoprazole is effective in combination regimens for Helicobacter pylori eradication, enhancing antibiotic efficacy by maintaining elevated gastric pH.
Drug Interaction Profile: Compared to other PPIs, pantoprazole shows minimal CYP2C19 inhibition, making it a preferred option in patients receiving clopidogrel or multiple concomitant medications.
Parenteral Use: Availability of intravenous formulation supports use in patients unable to take oral therapy, with proven efficacy in acute gastrointestinal bleeding management.
Long-Term Safety Evidence: Long-term studies indicate good tolerability; however, prolonged use may be associated with risks such as hypomagnesemia, vitamin B12 deficiency, and increased susceptibility to infections.
Current Research Focus: Ongoing research explores optimal duration of therapy, deprescribing strategies, and comparative effectiveness against newer acid-suppressing agents.
Patient Counseling Points ▼
Take 30–60 minutes before meals
Do not crush or chew capsules; swallow whole
Avoid excessive alcohol or NSAID use
Inform physician about other medications
Storage & Handling ▼
Store at 15–30°C, away from moisture & light
Keep out of reach of children
Medical Disclaimer: This clinical summary is for informational purposes only. Always follow guidance from a qualified healthcare professional for dosage, interactions, and use.

Medi News

[Medi News][twocolumns]